Antiparasitic Veterinary Medicinal Products
On 13 February 2019 the HPRA’s Advisory Committee for Veterinary Medicines (ACVM) established a Task Force to review the method of supply of antiparasitic veterinary medicinal products that are intended for food-producing animals against the criteria set out in Directive 2006/130/EC. This includes products containing all classes of antiparasitic agents and including medicines containing coccidostats.
The membership of the Task Force is as follows:
J. Gabriel Beechinor, Theo DeWaal, Caroline Garvan, Orla Keane, Joe O’Flaherty, James O’Shaughnessy and Aidan Moody.
Members possess specialist expertise and competence relevant to the functions of the task force. They are independent in the performance of their duties and, in accordance with their mandate, they may not be subject to the direction of any other person or body in the performance of their duties.
The Task Force held an on-line consultation with interested parties between 20 May and 21 June 2019. A summary of the results of that consultation is available here.
The Task Force expects to finalise the Report during October 2019. The Report will then be considered by the ACVM and, in December 2019, by the Authority of the HPRA. It is expected that the final report will be uploaded to this site, once the Authority has had time to consider it.
The terms of reference of the Task Force is available here. The classification criteria for veterinary medicinal products intended for use in food-producing animals that may be exempted from the requirement for a veterinary prescription is available here. Note that the criteria given in Article 34 of Regulation (EU) 2019/6 are essentially the same as those given in Directive 2006/130/EC.